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Cutaneous healing is a complex biological re-sponse after injury, serving to reestablish the barrier function of skin, but postoperative 
scarring can present a significant problem with pain, 
pruritus, functional impairment, poor aesthetics, 
and psychological morbidity.1
The propensity to cutaneous scarring differs by 
anatomical site, with presternal skin being particu-
larly prone to hypertrophic scarring and keloid 
Background: Adverse skin scarring varies by anatomical site with, for ex-
ample, presternal skin showing a greater hypertrophic response when 
compared with eyelid; such differences have traditionally been attributed 
to regional variations in skin tension, thickness, and Langer’s lines. Fibro-
blasts are the main cell implicated in fibrosis, and they too are known to 
show anatomical variation in their expression, differentiation, and intercel-
lular interactions. We, therefore, investigated whether intrinsic differences 
in skin fibroblasts derived from separate locations might contribute to the 
observed discrepancies in clinical scarring.
Methods: Primary in vitro cultures were established using matched eyelid 
and presternal skin from 3 healthy donors undergoing blepharoplasty sur-
gery. We used an in vitro collagen gel model of fibroblast-mediated tissue 
contraction to compare the properties of the dermal fibroblasts from each 
site. Cell contractile force and matrix stiffness were assessed in 3-dimen-
sional tissue constructs using an automated high-throughput device.
Results: Dermal fibroblasts isolated from eyelid and sternum differ both 
in their ability to contract a gel matrix and in their response to cytokine 
stimulation; despite having lower intrinsic contractile force (P < 0.01) 
and resting stiffness (P < 0.02), the presternal cells were more contractile 
(P < 0.001) following stimulation with serum, or inflammatory cytokines 
transforming growth factor-β (P < 0.01) and interleukin-1β (P < 0.05).
Conclusions: The propensity to cutaneous scarring may, at least in part, 
result from intrinsic differences in the local fibroblasts’ ability to contract 
and their sensitivity to inflammatory cytokines. Improved understanding 
of the underlying molecular pathways should prove useful in identifying 
new therapeutic targets for altering surgical and other scarring. (Plast 
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 formation.2 In contrast, periocular skin usually heals 
with imperceptible scars,3 and this has allowed good 
aesthetic results to be achieved with a “laissez faire” 
approach—in which a tissue defect is left to heal by 
secondary intention.4–7 Regional variability in scar-
ring has been attributed to anatomic differences 
in the orientation of skin tension lines and in skin 
thickness,5,6 with wounds under tension having been 
shown to scar excessively.7 Studies to compare site 
differences in the intrinsic properties of skin are lim-
ited, but these suggest wide variation in resting ten-
sion,8,9 stress, elasticity,10 and thickness—with eyelid 
skin being the thinnest.11 Although understanding 
the role of mechanical tension in scarring has re-
sulted in the development of stress-shielding devices 
to improve cutaneous scars,12 the many treatments 
for scarring—none of which has proved widely effec-
tive13—suggest that our understanding of the patho-
physiology of scar formation remains limited. It is, 
however, notable that embryonic tissues heal without 
scarring but later loose this ability, and such changes 
in the propensity to scarring have focused research 
on molecular signaling—with key cytokines [such 
as vascular endothelial growth factor, transforming 
growth factor-β (TGFβ), platelet-derived growth fac-
tor, interleukin-1β (IL1β), and epidermal growth 
factor] having been implicated in paracrine signal-
ing during scar formation.14
Fibroblasts are a key cell involved in wound re-
pair and collagen deposition, and their behavior 
is modulated by cytokines, stress, and intracellu-
lar and cell–matrix interactions—perturbations of 
which can contribute to excessive scars.15 Fibroblasts 
are a diverse group of cells, and their behavior and 
 expression profiles vary with anatomic location, for 
example, they show regional differences in their 
ability to support inflammatory cells, such as neutro-
phils and T-lymphocytes.16 Differentially expressed 
genes include those implicated in matrix synthesis, 
lipid metabolism, and signaling pathways control-
ling migration, proliferation, and eventual fate of 
the cells; indeed, it has been suggested that fibro-
blasts from different sites should be considered dis-
tinct cell types.17 This proposal has been confirmed 
in a subsequent study, in which expression profiles 
alone were used to identify, with 80% accuracy, the 
original anatomic locations of cultured fibroblasts.18
Prior research has generally focused on the prop-
erties of fibroblasts derived from scar tissue itself, and 
the intrinsic contractility, scarring, and biological di-
versity of healthy dermal fibroblasts from different 
locations have not been described. We conjectured 
that—when controlling for mechanical input and cul-
ture conditions—such dermal fibroblasts are likely to 
show differences in their contractile properties and 
responses to cytokine stimulation, and that this might 
be related to variability in the tendency to cutaneous 
scarring. Cutaneous fibroblasts were, therefore, iso-
lated from matched eyelid and presternal skin, and 
their contractile phenotype was characterized in our 
functional in vitro model of scar formation.19–21
MATERIAL	AND	METHODS
Clinical	Samples
This study adhered to the tenets of the Declaration 
of Helsinki and was approved by both local and regional 
ethics committees (Ethics approval ref 11/LO/1171). 
Upper eyelid skin biopsies and a 5-mm punch biopsy 
of presternal skin were obtained from 3 consecutive pa-
tients undergoing routine upper eyelid blepharoplasty, 
and these patients having given consent to the addi-
tional biopsy of presternal skin. Patients with previous 
eyelid or peristernal surgery were excluded.
All patients were Caucasian, and patient 1 was a 
female aged 47 years, patient 2 was a female aged 
53 years, and patient 3 was a male aged 62 years. 
None had a past medical history of chronic disease, 
hypertrophic cutaneous scarring, or keloid forma-
tion. Incisions were closed using subcuticular 6/0 
prolene that was removed after 1 week. Patients were 
reviewed after 3 months, and the scars were assessed 
using the Vancouver scar scale22 to clinically quantify 
the eyelid and the presternal scar formation.23,24
Isolation	of	Fibroblasts
Biopsy samples were wrapped in sterile gauze, moist-
ened with normal saline, and transported to the labora-
tory at +8°C. The biopsies were mechanically dispersed, 
and the tissue fragments placed in tissue culture dishes 
in Dulbecco’s modified Eagle’s medium (DMEM) with 
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high glucose (Invitrogen, Life Technologies, Paisley, 
UK), supplemented with 10% fetal bovine serum (FBS, 
Sigma-Aldrich, Gillingham, UK), 100 IU/mL penicil-
lin, 4.5 g/L of l-glutamine, and 100 g/mL streptomy-
cin (Invitrogen), and incubated at 37°C with 5% CO2. 
Following outgrowth from the explant, the fibroblast 
populations were trypsinized and maintained routinely 
in the above medium. The cells were used between pas-
sages 4 and 8 for all experiments.
Collagen	Contraction	Assay
These were performed according to the meth-
od described by Tovell et al.19 Briefly, fibroblasts 
were seeded in a 1.5 mg/mL collagen type-I ma-
trix (First Link UK Ltd, Wolverhampton, UK) at a 
concentration of 7 × 104 cells/mL in complete me-
dium. After polymerization at 37°C, the gels were 
detached from the edge of the well and 2 mL of 
culture medium added. Gel contraction was moni-
tored daily for 7 days by digital photography, the 
gel areas measured using ImageJ software (http://
rsb.info.nih.gov/ij/), and the contraction plotted 
as a percentage area normalized to the original 
area at day 0. For cytokine stimulation, the gels 
were made with 14 × 104 cells/mL in serum-free 
medium, with or without 5 ng/mL recombinant 
human TGFβ1 or 10 ng/mL IL1β (R&D Systems, 
Abingdon, UK)—placed in both the gel mix and 
the medium.
Force	Measurement	
A fibroblast suspension of 3.3 × 105 cells/mL in 
1.5 mg/mL collagen type-I in complete medium was 
pipetted as 300 μL/well into the MC-8 chamber (In-
vivoSciences, Madison, Wis.) and incubated at 37°C 
for 30 minutes, to complete polymerization. Then, 
350 μL of complete medium was added to each well, 
and the gels were incubated for 48 hours to form 
tissue-like matrices. The medium was changed to se-
rum-free DMEM for 18 hours before force measure-
ment. The MC-8 chamber was then placed on the 
stage of the Palpator device (InvivoSciences), which 
automatically stretches the matrices and measures 
the contractile force; to obtain stable measurements, 
the matrices were preconditioned by stretching 3 
times before force measurements. To measure force 
changes following serum stimulation, the serum-free 
medium was replaced with DMEM supplemented 
with 20% serum and the forces measured every 15 
minutes for 3 iterations. The samples were run as 
quadruplicates, and the force calculated from the 
average of the measurements from a minimum of 3 
experiments. A custom Matlab algorithm was used to 
analyze the data, and calculate cell contractile forces 
and matrix stiffness.25
Statistical	Analysis
All graphs display mean and standard error. Un-
less otherwise stated, all comparisons were  performed 
using the Student’s t test, and individual significance 
(α-risk) values are displayed.
RESULTS
Presternal	Fibroblasts	Display	Faster	Matrix		
Contraction,	when	Compared	with	Matched		
Eyelid-derived	Cells
Fibroblasts from pairs of eyelid and prester-
nal skins from 3 different donors established well 
in culture, displayed the characteristic elongated 
morphology of fibroblasts (irrespective of origin; 
Fig. 1), and showed comparable growth parameters, 
such as doubling time (data not shown). We used a 
validated in vitro model of cell-mediated collagen 
gel contraction19–21 to assess the contraction poten-
tial of these fibroblasts in the presence of 10% FBS, 
which classically mimics the early wound response. 
As expected from their dermal origin, both sets of fi-
broblasts were very efficient in contracting collagen 
gels, reaching 70% contraction by day 7 (Fig. 2). 
However, the early contraction was significantly 
faster for presternal cells (P < 0.01)—suggesting 
Fig. 1. presternal and eyelid cutaneous fibroblasts show 
similar morphology in standard monolayer cultures. Eyelid 
fibroblasts (a) display a typical elongated fibroblast shape, 
similar to that of their matching presternal counterpart cells 
(B). Bar = 100 μm.
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that they possess a greater intrinsic propensity to 
contraction in response to serum stimulation. Simi-
larly, review of the surgical incisions in our patients 
showed worse Vancouver scar scale scores (greater 
clinical scarring) for presternal incisions (mean 
4.3), when compared with blepharoplasty incisions 
(mean, 1.2; P = 0.005; Mann–Whitney U test).
Presternal	and	Lid	Cutaneous	Fibroblasts	Have	
Different	Mechanical	Properties
To investigate whether a greater cellular 
force might underlie the scarring propensity of 
presternal cutaneous fibroblasts, we used the 
Palpator—an automated device that measures 
cellular contractile force and extra-cellular ma-
trix rigidity in engineered 3-dimensional (3D) 
tissue matrices. Eyelid and presternal fibroblasts 
were cultured in specialized 3D chambers to gen-
erate contracted tissues at tensional equilibrium; 
these matrices were then incubated overnight in 
serum-free medium, and the cellular contractile 
force (Fig. 3A) and matrix elasticity (Fig. 3B) 
were assessed before and after stimulation with 
20% FBS (Fig. 3). When compared with eyelid-
derived fibroblasts, presternal cells showed a sig-
nificantly lower contractile force at rest (P < 0.01) 
and a lower matrix elastic force (P < 0.02). How-
ever, presternal fibroblasts showed a marked and 
significant increase in cellular force after serum 
stimulation (P < 0.001), whereas the increased 
contractile force of eyelid fibroblasts was not sta-
tistical significant. As expected,25 serum stimula-
tion did not significantly affect the matrix elastic 
force from either tissue (Fig. 3B).
Fig. 2. presternal cutaneous fibroblasts display increased early 
contraction of a collagen matrix after serum stimulation when 
compared with matching eyelid cells. Fibroblasts from the 
eyelid (red), or from the presternal area (blue), were embed-
ded in free-floating collagen matrices and monitored daily for 
7 days. Contraction is expressed as the percentage decrease in 
the gel area, relative to the area at time 0. Shown is the mean 
result of at least 3 experiments run in triplicate; error bars indi-
cate standard error. ** indicates significant difference, P < 0.01.
Fig. 3. presternal and eyelid cutaneous fibroblasts differ in their cell-force profiles: eyelid fibroblasts and presternal cells 
were cultured in collagen gels to generate 3D tissue-like matrices, which were then starved overnight in serum-free 
medium. Cellular force generation and tissue matrix rigidity were determined before (starved) and after stimulation with 
20% FBS for 15 minutes (stimulated). a, Eyelid cutaneous fibroblasts display greater intrinsic baseline cellular contractile 
force when compared with matching presternal fibroblasts under resting conditions (**, P < 0.01), but only presternal cells 
showed a significant increase in contractile force following stimulation (***, P < 0.001). B, matrices prepared with eyelid cu-
taneous fibroblasts displayed greater elastic force than those made with presternal cells (*, P < 0.02), with no change after 
serum stimulation.
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Presternal	Fibroblasts	Display	Increased	Cytokine-
induced	Matrix	Contraction
A range of inflammatory cytokines promote 
 fibroblast contraction after wounding, and  specific 
cytokines (such as TGFβ1 and IL1β) have been 
linked to tissue scarring and fibrosis. To assess 
whether the presternal cells’ increased propensity 
to serum-stimulated matrix contraction (Fig. 3) was 
linked to an increased sensitivity to inflammatory cy-
tokines, we performed gel contraction assays in the 
presence of either TGFβ1 or IL1β. As shown in Fig-
ure 4, neither eyelid nor presternal skin cells gener-
ated significant matrix contraction in the serum-free 
medium. However, after stimulation with either FBS, 
TGFβ1, or IL1β, fibroblasts from both tissues showed 
a significant increase in gel contraction (Fig. 4A, B; 
P < 0.05). Although gel contraction in response to in-
flammatory cytokines was minimal for eyelid-derived 
fibroblasts, both TGFβ1 and IL1β elicited a strong 
contraction response from presternal cells (Fig. 4C; 
P < 0.05), with TGFβ1 being particularly effective in 
promoting gel contraction.
DISCUSSION
Cutaneous wound healing is a complex process, 
and the biological mechanisms underlying a successful 
physiological resolution rather than a pathological scar-
ring outcome are still largely unknown.1 With eyelid in-
cisions usually healing well, and scar hypertrophy and 
keloids being common on the chest wall, we chose to 
use paired eyelid and presternal tissues for our study to 
represent opposite ends of the clinical spectrum of cu-
taneous scarring.2,3,5 Because fibroblasts are the prima-
ry drivers of scarring15 and their biological properties 
are known to vary with their anatomical origin,14,16–18,23 
we surmised that the strikingly different scarring be-
havior observed in eyelid and chest skin could reflect 
different properties of the local cutaneous fibroblasts. 
We used our well-characterized in vitro 3D model of 
tissue contraction21,26–29 to assess the contractile prop-
erties of the tissue-derived fibroblasts in classical free-
floating collagen gels and further analyzed the intrinsic 
mechanical properties of the cells within engineered 
tissues mimicking physiological environments.25
In line with their scarring potential in vivo, we 
found that presternal fibroblasts displayed greater 
matrix contraction ability in vitro when compared 
with eyelid cells, upon stimulation with both serum 
and inflammatory cytokines TGFβ1 and IL1β. As we 
have shown previously using a range of ocular cells, 
including fibroblasts isolated from scarred tissue,20,21 
our in vitro contraction assay using soft collagen gels 
is a good reflection of the potential of the cells for 
scarring in vivo.20,28,30 This implies that, upon tissue 
injury and local release of cytokines, presternal cells 
may have an inherent ability to generate more con-
tracture and scarring—an observation in accord with 
clinical experience. Interestingly, when the cells’ 
properties were analyzed within more physiological 
engineered tissues at tensional homeostasis, resting 
presternal fibroblasts were found to have a lower in-
trinsic cellular contractile force compared with eye-
lid cells, generating a tissue of overall slightly lower 
stiffness. This suggests that contrary to the tradition-
al belief that local tension lines are largely responsi-
ble for the abnormally high scarring potential of the 
chest tissue,2,5,6,31,32 local mechanical tension per se 
might not be the major factor underlying the fibro-
Fig. 4. presternal cutaneous fibroblasts show a greater contraction in response to inflammatory cytokines, when compared 
with those derived from matching eyelid skin. Fibroblasts were embedded in free-floating collagen matrices in a serum-
free medium, supplemented with either tGFβ1 (5 ng/ml) or il1β (10 ng/ml) and contraction monitored daily. Shown are 
typical contraction curves from a single patient’s eyelid skin (a) and presternal skin (B). the mean and standard error for 3 
experiments done in triplicate is shown. C, average contraction at day 7 is shown for matching eyelid and presternal fibro-
blast matrices for all 3 patients, normalized to the value of eyelid cells in a serum-free medium. Both sets of cells displayed 
a significant contractile response following cytokine stimulation, when compared with serum-free medium (*, P < 0.05; **, 
P < 0.01). However, presternal fibroblasts show a stronger response to tGFβ1 when compared with il1β (¶, P < 0.05), and a 
greater response to tGFβ1 when compared with that of eyelid-derived cells (§, P < 0.05).
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blasts’ propensity for scarring. Indeed,  although an 
increase in tension is usually linked to hypertrophic 
scarring,15,26,27 partly through an increase in the lo-
cal α-smooth muscle actin producing myofibroblast 
population,15 keloid scars on the other hand only 
have a minor contractile compartment, being large-
ly driven by cytokine-mediated stimulation of extra-
cellular matrix over-production.5,13–15 Despite their 
lower intrinsic force at rest, the presternal cells gen-
erated a stronger contractile force when stimulated 
with serum – consistent with the idea that increased 
sensitivity to serum components and cytokines upon 
wounding, as well as the ability to develop a greater 
contractile force, might underlie the propensity for 
presternal cutaneous scarring. This behavior is remi-
niscent of that of fibrotic fibroblasts isolated from 
the conjunctiva of patients with Floppy Eyelid Syn-
drome, whereby the diseased fibroblasts displayed 
increased collagen matrix contraction abilities,21 
despite the affected tissues of origin displaying a 
disorganized, much less stiff, matrix.30 This suggests 
that whilst fibroblasts’ behavior is adaptable and 
intimately linked to tissue biomechanics, their pro-
pensity to scar may eventually be down to how they 
respond to the local stimuli upon wounding.
Overall, the results presented here support our 
hypothesis that, when controlling for culture and me-
chanical environments, there are intrinsic differences 
in the mechanobiology of eyelid and presternal cu-
taneous fibroblasts. These intrinsic differences might 
be an important determinant in the formation of clin-
ically significant scarring. Differences in the resting 
tensions within, and rigidity of, engineered tissue ma-
trices derived from eyelid and presternal fibroblasts 
might also belie the traditional belief that differences 
in clinical scarring are solely related to tissue tension 
and skin thickness. Indeed, dermal fibroblasts popu-
lations are extremely heterogeneous,14,16–18,23 and the 
overall mixed populations that we have isolated may 
comprise various subsets of fibroblasts and fibroblast-
like cells, including mesenchymal stem cells.33–36 
Furthermore, as dermal fibroblasts from the face orig-
inate from the neural crest, whereas fibroblasts from 
the ventral skin are derived from the lateral plate 
mesoderm,34,35 and we cannot exclude the possibility 
that the differences we observed between the 2 popu-
lations are linked to the different anatomical origins 
of the cells analyzed. Although further studies will be 
needed to decipher the mechanisms at play, this pre-
liminary work suggests that local fibroblast behavior 
following wounding, and particularly, the response to 
inflammatory cytokines, may play a significant part in 
the scarring outcome and thus could be specifically 
targeted, in combination with the current measures 
to reduce tension, to minimize scarring. 
Maryse Bailly, PhD
Department of Cell Biology
UCL Institute of Ophthalmology
11–43 Bath Street
London EC1V 9EL, United Kingdom
Email: m.bailly@ucl.ac.uk 
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